MorphoSys AG is a biopharmaceutical company founded in 1992. The company is headquartered near Munich, Germany and has a wholly owned subsidiary, MorphoSys US Inc., in Boston MA in the US.
Company profile
Ticker
MOR, MPSYF
Exchange
Website
CEO
Simon Moroney
Employees
Incorporated
Location
Fiscal year end
Industry (SIC)
SEC CIK
MOR stock data
Latest filings (excl ownership)
6-K
Current report (foreign)
31 May 24
6-K
Current report (foreign)
29 May 24
6-K
Current report (foreign)
28 May 24
SC TO-T/A
Third party tender offer statement (amended)
24 May 24
6-K
Current report (foreign)
24 May 24
SC 14D9/A
Tender offer solicitation (amended)
23 May 24
6-K
Current report (foreign)
23 May 24
6-K
Current report (foreign)
23 May 24
6-K
Current report (foreign)
21 May 24
6-K
Current report (foreign)
17 May 24
Latest ownership filings
SC 13D/A
NOVARTIS AG
28 May 24
SC 13D
NOVARTIS AG
18 Apr 24
SC 13G
GOLDMAN SACHS GROUP INC
11 Mar 24
SC 13G/A
Kynam Capital Management, LP
8 Mar 24
SC 13G/A
T. Rowe Price Investment Management, Inc.
16 Feb 24
SC 13G
Kynam Capital Management, LP
14 Feb 24
SC 13G
T. Rowe Price Investment Management, Inc.
14 Feb 24
SC 13G
T. Rowe Price Investment Management, Inc.
14 Feb 23
SC 13G/A
FMR LLC
8 Feb 21
SC 13G/A
BlackRock Inc.
9 Oct 20
Financial summary
Quarter (USD) | Dec 23 | Dec 22 | Dec 21 | Dec 20 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Dec 23 | Dec 22 | Dec 21 | Dec 20 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Institutional ownership, Q1 2024
7.4% owned by funds/institutions
13F holders | Current |
---|---|
Total holders | 61 |
Opened positions | 58 |
Closed positions | 1 |
Increased positions | 1 |
Reduced positions | 1 |
13F shares | Current |
---|---|
Total value | 174.26 bn |
Total shares | 11.14 mm |
Total puts | 1.10 mm |
Total calls | 320.41 k |
Total put/call ratio | 3.4 |
Largest owners | Shares | Value |
---|---|---|
Glazer Capital | 1.45 mm | $26.30 mm |
Balyasny Asset Management | 1.30 mm | $23.65 bn |
UBS UBS Group AG - Registered Shares | 1.17 mm | $21.19 bn |
BLK Blackrock | 1.02 mm | $18.46 bn |
Carlson Capital L P | 950.46 k | $17.24 bn |
Tang Capital Management | 800.71 k | $14.52 bn |
Slotnik Capital | 655.52 k | $11.89 bn |
GS Goldman Sachs | 636.02 k | $11.54 bn |
Segantii Capital Management | 463.47 k | $8.41 bn |
Tudor Investment Corp Et Al | 343.31 k | $6.23 bn |